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Abstract
Identifying important biomarkers that are predictive for cancer patients’ progno-
sis is key in gaining better insights into the biological influences on the disease
and has become a critical component of precision medicine. The emergence of
large-scale biomedical survival studies, which typically involve excessive number
of biomarkers, has brought high demand in designing efficient screening tools for
selecting predictive biomarkers. The vast amount of biomarkers defies any exist-
ing variable selection methods via regularization. The recently developed variable
screening methods, though powerful in many practical setting, fail to incorporate
prior information on the importance of each biomarker and are less powerful in
detecting marginally weak while jointly important signals. We propose a new con-
ditional screening method for survival outcome data by computing the marginal
contribution of each biomarker given priorly known biological information. This
is based on the premise that some biomarkers are known to be associated with
disease outcomes a priori. Our method possesses sure screening properties and
a vanishing false selection rate. The utility of the proposal is further confirmed
with extensive simulation studies and analysis of a Diffuse large B-cell lymphoma
(DLBCL) dataset.
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1 Introduction
Despite much progress made in the past two decades, many cancers do not have a
proven means of prevention or effective treatments. Precision medicine that takes into
account individual susceptibility has become a valid approach to gaining better in-
sights into the biological influences on cancers, which is expected to benefit millions of
cancer patients. A critical component of precision medicine lies in detecting and iden-
tifying important biomarkers that are predictive for cancer patients’ prognosis. The
emergence of large-scale biomedical survival studies, which typically involve excessive
number of biomarkers, has brought high demand in designing efficient screening tools
for selecting predictive biomarkers. The presented work is motivated by a genomic
study of Diffuse large B-cell lymphoma (DLBCL) Rosenwald et al. (2002), with the
goal of identifying gene signatures out of 7399 genes for predicting survival among
240 DLBCL patients. The results may address whether the DLBCL patients’ survival
after chemotherapy could be regulated by the molecular features.
The recently developed variable screening methods, such as the sure independence
screening proposed by Fan and Lv (2008), have emerged as a powerful tool to solve
this problem, but their validity often hinges upon the partial faithfulness assumption,
that is, the jointly important variables are also marginally important. Consequently,
they will fail to identify the hidden variables that are jointly important but have
weak marginal associations with the outcome, resulting in poor understanding of the
molecular mechanism underlying or regulating the disease. To alleviate this problem,
Fan and Lv (2008) further suggested an iterative procedure (ISIS) by repeatedly
using the residuals from the previous iterations, which has gained much popularity.
However, the required iterations have increased the computational burden, and the
statistical properties are elusive.
On the other hand, intensive biomedical research has generated a large body
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of biological knowledge. For example, several studies have confirmed AA805575, a
Germinal-center B-cell signature gene, is relevant to DLBCL survival (Gui and Li
2005, Liu et al. 2013). Including such prior knowledge for improved accuracy in vari-
able selection has drawn much interest. Barut et al. (2016) proposed a conditional
screening (CS) approach in the framework of a generalized linear model (GLM) when
some prior knowledge on feature selection is known, and showed that the CS approach
provides a powerful means to identify jointly-informative but marginally weak asso-
ciations, and Hong et al. (2016) further proposed to integrate prior information using
data-driven approaches.
Development of high dimensional screening tools with survival outcome has been
fruitful. Some related work includes an (iterative) sure screening procedure for Cox’s
proportional hazards model (Fan et al. 2010), a marginal maximum partial likelihood
estimator (MPLE) based screening procedure (Zhao and Li 2012), a censored rank
independence screening method which is robust to outliers and applicable to a general
class of survival model (Song et al. 2014). But to the best of our knowledge, all these
methods essentially posit the partial faithfulness assumption and do not incorporate
the known prior biological information. As a result, they will be likely to suffer the
inability to identify marginally weak but jointly important signals.
To fill the gap, we propose a new conditional screening method for the Cox pro-
portional hazards model by computing the marginal contribution of each covariate
given priorly known information. We refer to it as Cox conditional screening (CoxCS).
As opposed to the conventional marginal screening methods, our method enables the
detection of marginally weak but jointly important signals, which will have important
biological applications as shown in the data example section. Moreover, in contrast
with most screening methods that usually employ subjective thresholds for screening,
we also propose a principled cut-off to govern the screening and control the false posi-
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tives in light of Zhao and Li (2012). This will be especially important in the presence
of hidden variables.
To demonstrate the utility of CoxCS in recovering important hidden variables,
we consider an example with 100 subjects and 1,000 covariates, where the survival
times were generated from a Cox model with baseline hazards function being 1, and
the covariates being generated from the multivariate standard normal distribution
with equal correlation 0.5. The true coefficients in the Cox model are set to be
β1 = . . . = β5 = 1 and β6 = −2.5 and βj = 0 for j ∈ {7, . . . , 1000}. By design,
variable 6 is the hidden variable in that it is marginally uncorrelated with survival
times approximately; see Example 1 in Section 4 for more details. Let β̂C,j denote the
screening statistics by the CoxCS approach (defined in Section 2), where C indexes
variables that are pre-included into the model. When C = ∅, the CoxCS is equivalent
to the marginal screening approach for the Cox proportional hazard model. Figure
1 summarizes the densities of the screening statistics for the hidden variable 6 and
noisy variables 10 to 1,000 for different sets of conditional variables based on 400 sim-
ulated datasets. The results show that with a high probability the marginal screening
statistic for hidden variable 6 is much smaller than those of noisy variables. When
the conditioning set includes one truly active variable, the density plots show a clear
separation between the hidden variables and the noisy variables. When we include
more truly active variables, this separation becomes larger. Interestingly, when con-
ditional on noisy variables that are correlated with both active and hidden variables
in the model, the chance of identifying the hidden variable using CoxCS is still higher
than the marginal screening. A similar phenomenon was observed in the GLM setting
(Barut et al. 2016). This is because when such “noisy” variables are correlated with
both marginally important variables and hidden variables, they may effectively func-
tion as surrogates for the active variables and conditioning on them can help detect
4
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hidden variables.
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Figure 1: Density of the screening statistics |β̂C,6| (red) for the hidden variable com-
pared with a mixture of densities of screening statistics |β̂C,11:1000| (blue) for the noise
variables with different conditioning sets: (A) C = {∅} which is equivalent to marginal
screening; (B) C = {1} one truly active variables; (C) C = {1, 2} two truly active
variables; (D) C = {7, . . . , 10} four noisy variables.
The theory of conditional screening for GLM has been established by Barut et al.
(2016). But its extension to the survival context is challenging and elusive, calling
for new techniques. To this end, we propose two new functional operators on ran-
dom variables to characterize their linear associations given other random variables:
the conditional linear expectation and the conditional linear covariance. Both are
critical to formulate the regularity conditions for the population level properties of
CoxCS with statistically meaningful interpretations, and facilitate the development
of theory for conditional screening approaches in general settings. A similar concept
of the conditional linear covariance has been introduced by Barut et al. (2016), but
it can not be used for the survival outcome data. In summary, the proposed method
is computationally efficient, adapts to sparse and weak signals, enjoys the good the-
oretical properties under weak regularity conditions, and works robustly in a variety
of settings to identify hidden variables.
The remaining of this paper is organized as follows. In Section 2, we review the Cox
proportional hazard model and present CoxCS approach with some alternatives. In
5
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Section 3, we list the regularity conditions and establish the sure screening properties.
In Section 4, we further conduct simulation studies to compare our method with the
major competing methods under under a number of scenarios. In Section 4, we apply
our method to study the DLBCL data. We conclude with a a brief discussion on the
future work in Section 5.
2 Model
2.1 The Cox Proportional Hazard Model
Suppose we have n observations with p covariates. Let i and j respectively in-
dex subjects and covariates. Denote by Zi,j covariate j for subject i, write Zi =
(Zi,1, . . . , Zi,p)
T. Let Ti be the underlying survival time and Ci be the censoring time.
We observe Xi = min{Ti, Ci}, and δi = I[Ti ≤ Ci], where I(·) is the indicator func-
tion. Assume that there exists τ > 0, such that P(Xi > τ | Zi) = 0 and assume that
the event time Ti and the censoring time Ci are independent. Suppose Ti follows a
Cox proportional hazards model
λ(t; Zi) = λ0(t) exp(α
TZi), (1)
where λ0(t) is an-unspecified baseline hazard and α = (α1, . . . , αp)
T is the true-
coefficient. Let Λ0(t) =
∫ t
0
λ0(s)ds be the cumulative hazard function. Suppose there
is a set of covariates that are known a priori to be related to the survival outcome.
Denote by C the indices of these covariates. Let q = |C| be the number of covariates
in C. Write Zi,C = (Zi,j, j ∈ C)T, Zi,−C = (Zi,j, j /∈ C)T, αC = (αj, j ∈ C)T and
α−C = (αj, j /∈ C)T. Note that in our problem, C is known but both αC and α−C are
unknown. Then the true hazard function in (1) is equivalent to
λ(t; Zi) = λ0(t) exp(α
T
CZi,C + α
T
−CZi,−C), (2)
To estimate αC and α−C, we introduce the independent counting process Ni(t) =
6
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I(Xi ≤ t, δi = 1) and the at-risk process Yi(t) = I[Xi ≥ t]. When p is small, we
can obtain the partial likelihood estimator α̂ = (α̂TC , α̂
T
−C)
T by solving the estimation
equation U(α) = 0p with U(α) = (U1(α), . . . , Up(α))
T and
Uj(α) =
n∑
i=1
∫ τ
0
{
Zi,j −
S
(1)
j (t,α)
S
(0)
j (t,α)
dNi(t)
}
, (3)
with
S
(m)
j (t,α) =
1
n
n∑
i=1
Zmi,jYi(t) exp(α
T
CZi,C + α
T
−CZi,−C), (4)
for m ∈ {0, 1, 2, . . . , }. When p > n, it is computationally and theoretically infeasible
to directly solve the equation (6). By imposing sparsity on the coefficients, one may
maximize the penalized partial likelihood to obtain solutions. However, when p >> n,
we need to employ a variable screening procedure first before performing regularized
regression. We propose a new conditional screening procedure in the next section.
2.2 Cox Conditional Screening
We fit the marginal Cox regression by including the known covariates in C. Specifi-
cally, for j /∈ C, we have the following marginal Cox regression model
λj(t; Zi) = λj,0(t) exp(β
T
CZi,C + βZi,j), (5)
from which the maximum partial likelihood estimation equation (β̂
T
C,j, β̂j)
T can be
obtained. It is given by the solution of the following equation:
Vj(βC, β) = [Vj,k(βC, β), k ∈ C ∪ {j}]T = 0q+1, (6)
with
Vj,k(βC, β) =
n∑
i=1
∫ τ
0
{
Zi,k −
R
(1)
j,k(βC, β, t)
R
(0)
j,k(βC, β, t)
dNi(t)
}
, (7)
and
R
(m)
j,k (βC, β, t) =
1
n
n∑
i=1
Zmi,kYi(t) exp(β
T
CZi,C + βZi,j), (8)
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for k ∈ C ∪ {j} and m ∈ {0, 1, 2, . . .}. For a given threshold γ > 0. The selected
index set in addition to set C is given by
M̂−C =
{
j /∈ C : |β̂j| ≥ γ
}
. (9)
Namely, we recruit variables with large additional contribution given ZC. We refer to
this method as Cox conditional screening (CoxCS).
3 Theoretical Results
We establish the theoretical properties of the proposed methods by introducing a few
new definitions along with the basic properties.
3.1 Definitions and Basic Properties
Let (Ω,F ,P) be the probability space for all random variables introduced in this
paper, where Ω is the sample space, F is the σ-algebra as the set of events and P is the
probability measure. Let Rd be a d-dimensional Euclidean vector space, for positive
integer d. Denote by E[•], Var[•] and Cov[•, •] the commonly used expectation,
variance and covariance operator in the probability theory, respectively. For any
d ≥ 1, any random variable ξ : Ω → Rd and any operator A, denote by A[• | ξ]
conditional A of • given ξ. For any vector a = (a1, . . . , ap) ∈ Rp, let aC = (aj, j ∈ C)T
be the sub vector where all its elements are indexed in C. Let ‖a‖d = d
√∑p
j=1 |a|dj be
the L-d norm for any vector a ∈ Rp. For a sequence of random variables indexed by
{ξn}, ξn = op(1) if and only if for any 1 > 0 and 2 > 0, there exists N such that for
any n > N P[|ξn| > 1] < 2.
For simplicity, let T , C, X, Y (t), Zj, Z and δ represent Ti, Ci, Xi, Yi(t), Zi,j,
Zi and δi respectively, by removing the subject index i. Let ST (t | Z) and SC(t)
represent the survival functions for the event time T and censored time C. Let
FT (t | Z) = 1− ST (t | Z).
8
http://biostats.bepress.com/umichbiostat/paper117
Definition 1. Let M−C = {j /∈ C, αj 6= 0} and w =
∑
j /∈C I[αj 6= 0] be the true
set of non-zero coefficients and its cardinality in model (1), aside from the important
predictors known a priori.
To study the asymptotic property of (β̂
T
C,j, β̂j)
T, define the population level quan-
tity as follows:
Definition 2. Let (βTC,j, βj)
T be the solution of the following equations
vj(βC, β) = [vj,k(βC, β), k ∈ C ∪ {j}]T = 0q+1, (10)
with
vj,k(βC, β) =
∫ τ
0
[
s
(1)
k (t)−
r
(1)
j,k (t,βC, β)
r
(0)
j,k (t,βC, β)
s
(0)
k (t)
]
dt, (11)
where s
(m)
k (t) = E [Z
m
k dN(t)] and r
(m)
j,k (t,βC, β) = E[R
(m)
j,k (t,βC, β)].
Definition 3. Let βC,0 be the solution of the following equations
vC(βC) = [vj,k(βC, 0), k ∈ C]T = 0q. (12)
Proposition 1. vj(βC,0, 0) = 0q+1 if and only if vj,j(βC,0, 0) = 0, for all j ∈ C.
To understand the intuition of the population level properties for the Cox con-
ditional screening, we need to define a conditional linear expectation. A similar
concept has been used to study the conditional sure independence screening (CSIS)
in the GLM setting by Barut et al. (2016). We provide a formal definition here.
Definition 4. For two random variables ζ : Ω→ Rd and ξ : Ω→ Rp. The conditional
linear expectation of ζ given ξ is defined as
E∗(ζ | ξ) = E[ζ] + AT{ξ − E(ξ)}, (13)
where A = argminB∈Rd×Rp E[(ζ − E[ζ] − BT{ξ − E(ξ)})2 | ξ]. Also, define notation
E∗(ζ) = E(ζ).
9
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The basic properties of the conditional linear expectation are listed in the following
proposition.
Proposition 2. Let ζ, ζ1, ζ2 and ξ be any four random variables in the probability
space (Ω,F ,P). The following properties hold for the conditional linear expectation
E∗[• | ξ] given ξ:
1. Closed form: E∗(ζ | ξ) = E[ζ] + Cov(ζ, ξ)Var[ξ]−1{ξ − E(ξ)}.
2. Stability: E∗[ξ | ξ] = ξ.
3. Linearity: E∗[A1ζ1 + A2ζ2 | ξ] = A1E∗[ζ1 | ξ] + A2E∗[ζ2 | ξ], where A1 and
A2 are two matrices that are compatible with the equation.
4. Law of total expectation: E∗[E∗(ζ | ξ)] = E[E∗(ζ | ξ)] = E[ζ].
Remark 1. In general, E∗(ζ | ξ) 6= E(ζ | ξ). Also, ζ and ξ are independent does not
imply E∗(ζ | ξ) = 0, unless ζ and ξ are jointly normally distributed.
Definition 5. For any random variables ζ1 : Ω→ Rd1, ζ2 : Ω→ Rd2 and ξ : Ω→ Rp.
The conditional linear covariance between ζ1 and ζ2 given ξ is defined as
Cov∗(ζ1, ζ2 | ξ) = E∗[{ζ1 − E∗(ζ1 | ξ)}{ζ2 − E∗(ζ2 | ξ)} | ξ]. (14)
Remark 2. By Proposition 2, we can easily verify the following properties.
Proposition 3. The conditional linear covariance defined in definition 5 has the
following properties
1. Linear independence and linear zero correlation:
Cov∗(ζ1, ζ2 | ξ) = 0 ⇔ E∗(ζ1ζ2 | ξ) = E∗(ζ1 | ξ)E∗(ζ2 | ξ).
2. Expectation of conditional linear covariance:
E[Cov∗(ζ1, ζ2 | ξ)] = Cov(ζ1, ζ2)− Cov(ζ1, ξ)Var(ξ)−1Cov(ξ, ζ2).
10
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3. Sign: for any increasing function h(·) : R→ R and random variable η : Ω→ R,
then
Cov∗(h(η), η | ξ) ≥ 0.
Definition 6. Define
vj(βC, β) = vj,j(βC, β) +
∑
k∈C
akvj,k(βC, β),
where vector aC = [ak, k ∈ C]T such that E∗[Zj | ZC] =
∑
k∈C akZk.
Proposition 4. vj,j(βC,0, 0) = 0 if and only if vj(βC,0, 0) = 0.
3.2 Regularity Conditions
We list all conditions for the theoretical results.
Condition 1. For each j /∈ C and k ∈ C ∪ {j}, there exists a neighborhood of
(βTC,j, βj)
T, which is defined as
Bj = {(βTC , β)T : ‖(βTC , βj)T − (βTC,j, βj)T‖1 < δj}, with δj > 0,
such that for each τ <∞,
1. For m = 0, 1,
sup
t∈[0,τ ],(βTC ,β)T∈Bj
‖R(m)j,k (βC, β)− r(m)j,k (βC, β)‖2 → 0,
in probability as n→∞.
2. There exists a constant L > 0 such that
L = min
j /∈C
[
inf
t∈[0,τ ],(βTC ,β)T∈Bj
{r(0)j,k (βC, β, t)}
]
.
Of note, {r(0)j,k (βC, β, t)} does not depend on k. Let δ = maxj /∈C δj.
11
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Condition 2. The covariates Zj’s satisfy the following conditions
1. For j ∈ {1, . . . , p}, E[Zj] = 0 and there exists a constant K0 such that P(Zj >
K0) = 0.
2. Zj is a time constant variable, for all j.
3. All Zj’s, j ∈M−C are independent of all Zk’s, k /∈M−C given ZC.
4. For constant c1 > 0 and κ < 1/2,
min
j∈M−C
|E[Cov∗(Zj,P[δ = 1 | Z] | ZC)])| ≥ c1n−κ.
Condition 3. There exists a constant K1 such that
‖α‖1 < K1 and ‖(βTC,j, βj)T‖1 < K1,
for all p > 0.
Condition 4. For all j /∈ C, there exists a constant M > 0 such that
M‖(β̂TC,j, β̂j)T − βTC,j, βj)T‖2 ≤ ‖Vj(β̂C,j, β̂j)−Vj(βC,j, βj)‖2.
3.3 Properties on Population Level
Lemma 1. The solution of vj(βC, β) = 0q+1 and the solution of vC(βC) = 0q are
both unique, for any j /∈ C.
Theorem 1. Suppose Condition 2 hold, βj = 0 if and only if αj = 0 for all j /∈ C.
Theorem 2. Suppose Condition 2 holds. There exist constants c2 > 0 and κ < 1/2
such that
min
j∈M−C
|βj| ≥ c2n−κ.
12
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3.4 Properties on Sample Level
Theorem 3. Suppose Conditions 1–4 hold. For any 1 > 0 and any 2 > 0, there
exits positive constants c3, c4 and integer N such that for any n > N ,
1. For any 0 < κ < 1/2,
P
[
max
j∈M−C
|β̂j − βj| > c2
2
(n−κ − 1)
]
≤ 2w(q + 1) exp(−c3n1−2κ) + 2.
where w is the size of M−C, q is the size of C and c2 is the same value in
Theorem 2 and c3 does not dependent on 1, 2 and κ, but N depends on 1 and
2.
2. If γn = c4n
−κ, where κ is the same number in Condition 2, then
P
[
min
j∈M−C
|β̂j| > γn
]
≥ 1− 2w(q + 1) exp(−c3n1−2κ)− 2. (15)
where c4 does not depend on 1, 2 and κ, thus
lim
n→∞
P
[
M−C ⊆ M̂−C
]
= 1. (16)
3.5 Controlling the False Discover Rate
Define the information matrix
Ij(βC, βj) = −
(
∂Vj,k(βC, βj)
∂βk′
)
k,k′∈C∪{j}
, (17)
which is of q+ 1 dimension. Denote σ̂2j = [Ij(βC,j, β̂j)]
−1
q+1,q+1 be the variance estimate
of β̂j. For a given threshold γ > 0, we can have a different way to select the index
which is given by
M̂∗−C =
{
j /∈ C : |β̂j|
σ̂j
≥ γ
}
, (18)
as suggested by Zhao and Li (2012). We refer to (18) as “CS-Wald”.
13
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Another alternative to construct the screening statistics, which is also scale free,
is to utilize the partial log likelihood ratio statistic. Specifically,
`(βC, β) =
n∑
i=1
∫ τ
0
{
βTCZi,C + βZi,j − log
(
R
(0)
j,k(βC, β, t)
)
dNi(t)
}
. (19)
Suppose (β̂
T
C,j, β̂j)
T maximizes (19) for a given j. Then, for a given threshold
γ > 0, the index set can be chosen by considering the following likelihood ratio
statistic.
M̂∗−C =
{
j /∈ C : `(βˆC,j, βˆj)− `(βˆC,0, β = 0) ≥ γ
}
, (20)
where βˆC,0 maximizes `(βC, 0). Hereafter (20) will be referred to as “CS-PLIK”.
4 Simulation Studies
The utility of the proposed methods was evaluated via extensive simulations. De-
note by CS-MPLE, a version of CoxCS that is based on the criteria of (9). For
completeness, we considered two other variations of CoxCS, namely, CS-PLIK and
CS-Wald. The finite sample performance of the proposed methods was compared
with the following marginal screening methods designed for the survival data.
• CRIS: censored rank independence screening proposed by Song et al. (2014).
• CORS: correlation screening, which is an extension of sure independence screen-
ing to the censored outcome data by using inverse probability weighting; see Song
et al. (2014).
• PSIS-Wald: Wald test based on the marginal Cox model fitted on each covariate;
see Zhao and Li (2012).
• PSIS-PLIK: partial likelihood ratio test based on the marginal Cox model fitted
on each covariate, which is asymptotically equivalent to Zhao and Li (2012).
14
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We illustrated our methods and compared them with the competing methods on
data simulated as below.
Example 1. The survival time was generated from a Cox model with baseline hazards
function being set to be 1, i.e.,
λ(t | Z) = exp(βTZ),
where Z were generated from the standard normal distribution with equal correlation
0.5 and β = (1T5 ,−2.5,0Tp−6)T.
Example 2. The survival time was generated from a Cox model with baseline hazards
function being set to be 1, i.e.,
λ(t | Z) = exp(−1 + βTZ),
where β = (10,0Tp−2, 1)
T and all covariates were generated from the independent
standard normal distribution.
Example 3. The same as Example 2 except that the first p − 1 covariates were gen-
erated from the multivariate standard normal distribution with an equal correlation
of 0.9.
The simulated data examples were designed in such a way that variables Z6 in
Example 1 and Zp in Example in 3 possessed marginally weak but conditionally strong
signals, which made marginal screening approaches not ideal for identifying them. For
the GLM, Barut et al. (2016) provided a similar simulation design in the context of
non-censored regression. Figure 3 depicted the distribution of the absolute correlation
between the survival time and the covariate variables, where uncensored data were
used to compute the marginal correlation between the event time and the covariate
using an inverse probability weighting (Song et al. 2014). Clearly, in Example 1
the marginal signal strength of Z6 was weaker than most noisy (inactive) variables
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Figure 2: Absolute correlation of the survival time and the covariate variables. The
blue short-dashed lines (· · · · ·) represents the distribution of the inactive variables; the
green long-dashed (– – –) lines for the active variables with relatively strong signals;
the red solid lines (——) for the hidden active variable.
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(Z7 − Z1000), while the marginal signal strength of Z1000 in Examples 2 and 3 was
similar or even lower than most noisy variables. The marginal correlation between
the survival time and each variable was getting weaker with heavier censoring.
In all these examples, the censoring times Ci were independently generated from
a uniform distribution U [0, c], with c chosen to give approximately 20% and 60% of
censoring proportions. We set n = 100 and varied p from 1000 (high-dimensional)
to 10000 (ultrahigh-dimensional). For each configuration, a total of 400 simulated
datasets were generated.
We considered two metrics to compare the performance between different methods:
the minimum model size (MMS) which is the minimum number of variables that need
to be selected in order to include all active variables, and the true positive rate (TPR)
which is the proportion of active variables that are included in the first n selected
variables. Hence, a method with small MMS and large TPR can be more efficient
to discover true signals. To have a fair comparison, we added one (the number of
conditioning variable in our examples) to MMS for the proposed methods (CS-MPLE,
CS-Wald and CS-PLIK). In practice, identifying conditional sets normally requires
some prior biological information. In our simulations, we simply choose the covariate
Z1 as the conditioning variable. In practice, we propose to choose the variable with
the highest marginal signal strength as the conditioning variable, which can be a
practical solution in the absence of prior biological knowledge. In Examples 1–3,
C = {1} is the true conditioning set, the signal of which was strong enough to be
easily selected by other marginal screening methods.
Table 1 demonstrated the superiority of our proposed methods under the difficult
scenarios as reflected in Examples 1–3. Indeed, the proposed methods drastically
reduced MMS in Examples 1–3 compared to the marginal approaches. Moreover, we
noted that all the marginal screening methods had tremendous difficulties in identi-
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Figure 3: Median number of active variables that are included in the model with
different thresholds by different methods
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fying Z6 in Example 1 and Z1000 in Examples 2–3. Indeed, these variables had the
lowest priorities to be included by using the competing methods. On the other hand,
the proposed approaches greatly outperformed the marginal approaches, as the condi-
tioning approaches effectively boosted the signal strengths of the “hidden” variables.
The performance by CS-MPLE, CS-Wald and CS-PLIK are quite similar in all the
cases in Examples 1 and 2. In Example 3, there is a very high correlation among the
covariate variables, CS-MPLE has a slightly larger MMS compared to the CS-Wald
and CS-PLIK which well control the false discover rate in this cases.
5 Application
We illustrated the practical utility of the proposed method by applying it to analyze
the diffuse large B-cell lymphoma (DLBCL) dataset of Rosenwald et al. (2002). The
dataset, which was originally collected for identifying gene signatures relevant to the
patient survival from time of chemotherapy, included a total of 240 DLBCL patients
with 138 deaths observed during the followup and a median survival time of 2.8 years.
Along with the clinical outcomes, the expression levels of 7,399 genes were available
for analysis. In our subsequent analysis, each gene expression was standardized to
have mean zero and variance 1.
To facilitate the use of our method, we identified the conditional set by resorting to
the medical literature. As gene AA805575, a Germinal-center B-cell signature gene,
has been known to be predictive to DCBCL patients’ survival in the literature (Liu
et al. 2013, Gui and Li 2005), we used it as the conditional variable in our proposed
procedure. For comparisons, we also analyzed the same data using various compet-
ing methods introduced in the simulation section and computed the corresponding
concordance statistics (C-statistics) (Uno et al. 2011).
Specifically, we randomly assigned 160 patients to the training set and 80 patients
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(n, p) = (100, 1000) (n, p) = (100, 10000)
Method MMS TPR MMS TPR
CRIS 1000.0 (3.0) 0.50 (0.17) 9995.0 (37.0) 0.17 (0.17)
CORS 944.0 (168.2) 0.33 (0.33) 9466.0 (1101.8) 0.00 (0.17)
Example 1 PSIS-PLIK 1000.0 (0.0) 0.67 (0.17) 10000.0 (2.2) 0.33 (0.17)
CR ≈ 20% PSIS-Wald 1000.0 (0.0) 0.67 (0.17) 10000.0 (2.2) 0.33 (0.17)
CS-PLIK 152.5 (272.2) 0.83 (0.17) 1322.0 (2253.8) 0.67 (0.17)
CS-Wald 154.5 (274.5) 0.83 (0.17) 1286.5 (2287.0) 0.67 (0.17)
CS-MPLE 143.0 (249.0) 0.83 (0.17) 1321.0 (2305.8) 0.50 (0.17)
CRIS 926.5 (151.8) 0.33 (0.17) 9429.0 (1405.0) 0.00 (0.17)
CORS 898.0 (152.2) 0.00 (0.17) 8976.0 (1610.0) 0.00 (0.00)
Example 1 PSIS-PLIK 1000.0 (2.0) 0.67 (0.17) 9999.0 (17.0) 0.33 (0.17)
CR ≈ 60% PSIS-Wald 1000.0 (2.0) 0.67 (0.17) 9999.0 (17.0) 0.33 (0.17)
CS-PLIK 227.0 (351.2) 0.83 (0.17) 2383.5 (3331.5) 0.50 (0.33)
CS-Wald 227.5 (348.2) 0.83 (0.17) 2403.5 (3233.2) 0.50 (0.33)
CS-MPLE 228.5 (320.5) 0.83 (0.17) 2229.5 (3046.8) 0.50 (0.17)
CRIS 262.5 (401.8) 0.50 (0.00) 2871.0 (4314.0) 0.50 (0.00)
CORS 490.5 (510.8) 0.50 (0.00) 4878.5 (5099.8) 0.50 (0.00)
Example 2 PSIS-PLIK 318.0 (492.8) 0.50 (0.00) 3777.0 (5690.8) 0.50 (0.00)
CR ≈ 20% PSIS-Wald 318.5 (494.2) 0.50 (0.00) 3786.5 (5707.8) 0.50 (0.00)
CS-PLIK 2.0 (0.0) 1.00 (0.00) 2.0 (0.0) 1.00 (0.00)
CS-Wald 2.0 (0.0) 1.00 (0.00) 2.0 (0.0) 1.00 (0.00)
CS-MPLE 2.0 (0.0) 1.00 (0.00) 2.0 (0.0) 1.00 (0.00)
CRIS 399.5 (478.0) 0.50 (0.00) 3601.0 (4894.2) 0.50 (0.00)
CORS 603.5 (390.5) 0.00 (0.00) 5988.0 (4353.0) 0.00 (0.00)
Example 2 PSIS-PLIK 325.0 (498.5) 0.50 (0.00) 3942.5 (5679.5) 0.50 (0.00)
CR ≈ 60% PSIS-Wald 322.0 (501.0) 0.50 (0.00) 3915.5 (5679.5) 0.50 (0.00)
CS-PLIK 2.0 (0.0) 1.00 (0.00) 2.0 (1.0) 1.00 (0.00)
CS-Wald 2.0 (0.0) 1.00 (0.00) 2.0 (2.0) 1.00 (0.00)
CS-MPLE 2.0 (0.0) 1.00 (0.00) 2.0 (4.0) 1.00 (0.00)
CRIS 1000.0 (0.0) 0.50 (0.00) 10000.0 (0.0) 0.50 (0.00)
CORS 1000.0 (0.0) 0.50 (0.50) 10000.0 (0.0) 0.00 (0.00)
Example 3 PSIS-PLIK 1000.0 (0.0) 0.50 (0.00) 10000.0 (0.0) 0.50 (0.00)
CR ≈ 20% PSIS-Wald 1000.0 (0.0) 0.50 (0.50) 10000.0 (0.0) 0.00 (0.50)
CS-PLIK 2.0 (0.0) 1.00 (0.00) 2.0 (0.0) 1.00 (0.00)
CS-Wald 2.0 (0.0) 1.00 (0.00) 2.0 (0.0) 1.00 (0.00)
CS-MPLE 3.0 (4.0) 1.00 (0.00) 7.5 (33.0) 1.00 (0.00)
CRIS 1000.0 (0.0) 0.50 (0.00) 10000.0 (0.0) 0.50 (0.00)
CORS 783.0 (463.8) 0.00 (0.50) 7967.0 (4972.2) 0.00 (0.00)
Example 3 PSIS-PLIK 1000.0 (0.0) 0.50 (0.00) 10000.0 (0.0) 0.50 (0.00)
CR ≈ 60% PSIS-Wald 1000.0 (0.0) 0.00 (0.00) 10000.0 (0.0) 0.00 (0.00)
CS-PLIK 2.0 (0.0) 1.00 (0.00) 2.0 (0.0) 1.00 (0.00)
CS-Wald 2.0 (0.0) 1.00 (0.00) 2.0 (0.0) 1.00 (0.00)
CS-MPLE 20.0 (55.2) 1.00 (0.00) 161.5 (553.5) 0.50 (0.50)
Table 1: Median minimum model size (MMS) and median true positive rates (TPR)
along with their corresponding IQRs (in the parentheses) based on 400 simulated
data sets.
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to the testing set, while maintaining the censoring proportion roughly the same in
each set. For each split, we applied each method to select top 31(= 160/ log(160))
variables using the training set. LASSO was performed subsequently for refined
modeling, with the tuning parameter selected by the 10-fold cross-validation. The
risk score for each subject was obtained by using the final model selected by LASSO
in the training dataset and the C-statistics was obtained in the testing dataset. A
total of 100 splits were made and the average C-statistics and the model size (MS)
were reported in Table 2. By the criterion of C-statistics, the proposed method seemed
to have more predictive power.
CRIS CORS PSIS-PLIK PSIS-Wald
C-statistics 0.54 (0.21) 0.58 (0.20) 0.58 (0.19) 0.55 (0.20)
Model size 14.41 (3.00) 6.83 (3.70) 15.22 (2.93) 15.65 (2.89)
CS-MPLE CS-PLIK CS-Wald
C-statistics 0.63 (0.18) 0.63 (0.18) 0.62 (0.19)
Model size 16.74 (3.26) 15.90 (3.01) 16.28 (3.41)
Table 2: Summary of C-statistics and the model size for different methods.
Our further scientific investigation focused on identifying the relevant genes by
utilizing the full dataset. Applying our proposed method, we selected top 44 (=
240/ log(240)) genes, before using LASSO to reach the final list. It follows that CS-
MPLE, CS-PLIK and CS-Wald selected 20, 16 and 16 genes, respectively. Among
the 22 uniquely selected genes by either of them, 14 genes were overlapped and were
reported in Table 3. Twelve genes among these 22 genes belong to Lymph-node sig-
nature group, proliferation signature group, and Germinal-center B-cell group defined
by Rosenwald et al. (2002). We observed that 13 of these 22 genes were chosen by
at least one of CRIS, CORS, PSIS-PLIK, and PSIS-Wald. On the other hand, gene
AB007866, Z50115, S78085, U00238, AL050283, J03040, U50196, and AA830781, and
M81695 were only identified by using our methods.
21
Hosted by The Berkeley Electronic Press
In fact, only a few studies have suggested an important role of M81695 (Deb and
Reddy 2003, Chow et al. 2001, Mikovits et al. 2001, Stewart and Schuh 2000) or
AA830781 (Li and Luan 2005, Binder and Schumacher 2009, Schifano et al. 2010)
in predicting DLBCL survival. Indeed, as the marginal correlation between M81695
and the survival time and between AA830781 and the survival time are markedly
low at 0.008 and 0.097, respectively. Thus, it is highly likely to be missed by using
the conventional screening approaches. Schifano et al. (2010) also commented their
majorization-minimization algorithm selected AA830781 because of coexpression or
correlation with other relevant genes. A more detailed investigation of its functions
in the context of a broader class of blood cancers, including lymphoma, may shed
light on preventing, treating and controlling the lethal blood cancers.
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6 Discussion
In this paper, we have proposed a new conditional variable screening approach for
the Cox proportional hazard model with ultra-high dimensional covariates. The pro-
posed partial likelihood based conditional screening approaches are extremely com-
putationally efficient, with a solid theoretical foundation. Our method and theory
are extensions of the conditional sure independence screening (CSIS) Barut et al.
(2016), which is designed for the GLM. In the development of theory, we introduce
the new concept of the conditional linear covariance for the first time, which is useful
to specify the regularity conditions for the model identifiability and the sure screening
property. This also provides a solid building block for a general theoretical framework
of conditional variable screening in the context of other semi-parametric models, such
as the partially linear single-index model.
We have mainly focused on studying the theoretical properties of CS-MPLE, which
extends the work of Barut et al. (2016) in the GLM setting, though development of
the inference procedures for the two variants of the proposed method, namely, CS-
PLIK and CS-Wald, will be more involved and out of scope of this paper. However,
as indicated by the simulation studies, these two variants may induce substantial
improvement especially when the variables are highly correlated. More research is
warranted.
Our work also enlightens a few directions that are worth ensuing effort. First, as
our proposal requires the prior information to be known and informative, it remains
statistically challenging to develop efficient screening methods in the absence of such
information. Recently, in the context of GLM, Hong et al. (2016) has proposed a
data-driven alternative when a pre-selected set of variables is unknown. It is thus
of substantial interest to develop a data-driven conditional screening for the survival
model. Second, even with prior knowledge, an open question often lies in how to
24
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balance it with the information extracted from the given data. There has been some
recent work on how to incorporate prior information. For example, Wang et al. (2013)
developed a LASSO method by assigning different prior distributions to each subset
according to a modified Bayesian information criterion that incorporates prior knowl-
edge on both the network structure and the pathway information, and Jiang et al.
(2015) proposed “prior lasso” (plasso) to balance between the prior information and
the data. A natural extension of the current work is to develop a variable screen-
ing approach that incorporates more complex prior knowledge, such as the network
structure or the spatial information of the covariates. We will report the progress
elsewhere.
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7 Appendix
7.1 Proof of Theorem 1
Proof. First we make the connection between βj to the expected conditional linear
covariance between Zj and P[δ = 1 | Z] given ZC, that is
E[Cov∗(Zj,P[δ = 1 | Z] | ZC)],
then by Condition 2, we relate it to αj. For any j /∈ C and k ∈ C, it is straightforward
to see that
s
(m)
k (t) = E[Z
m
k λ0(t) exp(Z
Tα)ST (t | Z)SC(t)], (21)
and
r
(m)
j,k (t,βC, β) = E[Z
m
k exp(Z
T
CβC + Zjβ)ST (t | Z)SC(t)], (22)
for m = 0, 1. Then
vj,k(βC, β)
=
∫ τ
0
E
[
Wj,k(t,βC, β) exp(Z
Tα)ST (t | Z)SC(t)λ0(t)
]
dt, (23)
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where
Wj,k(t,βC, β) = Zk −
E[Zk exp(Z
T
CβC + Zjβ)ST (t | Z)SC(t)]
E[exp(ZTCβC + Zjβ)ST (t | Z)SC(t)]
.
By Proposition 2,
E
[
Wj,k(t,βC, β) exp(Z
Tα)ST (t | Z)SC(t)
]
= E
{
E∗
[
Wj,k(t,βC, β) exp(Z
Tα)ST (t | Z)SC(t)
]}
.
By Definition 6,
vj(βC, β) = vj,j(βC, β)−
∑
k∈C
akvj,k(βC, β)
= E [Cov∗(Zj,P[δ = 1 | Z] | ZC)]− g(βC, β).
where
E [Cov∗(Zj,P[δ = 1 | Z] | ZC)]
=
∫ τ
0
E
[
(Zj − E∗[Zj | ZC]) exp(ZTα)ST (t | Z)SC(t)λ0(t)
]
dt,
and
gj(βC, β)
=
∫ τ
0
E[(Zj − E∗[Zj | ZC]) exp(ZTCβC + Zjβ)ST (t | Z)SC(t)]
E[exp(ZTCβC + Zjβ)ST (t | Z)SC(t)]
×E [exp(ZTα)ST (t | Z)λ0(t)SC(t)] dt.
By Definition 2, vj(βC,j, βj) = 0q+1,
gj(βC,j, βj) = E [Cov
∗(Zj,P[δ = 1 | Z] | ZC)] .
When αj = 0, then E [Cov
∗(Zj,P[δ = 1 | Z] | ZC)] = 0. Thus gj(βC,j, βj) = 0.
Also, by Propositions 1 and 2, gj(βC,0, 0) = 0, then vj(βC,0, 0) = 0q+1. By uniqueness
in Lemma 1, βj = 0.
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When αj 6= 0, by Condition 2, we have
|gj(βC,j, βj)| = |E [Cov∗(Zj,P[δ = 1 | Z] | ZC)] | > c1n−κ.
This implies that gj(βC,j, βj) and E [Cov
∗(Zj,P[δ = 1 | Z] | ZC)] are both nonzero and
have the same signs since they are equal. Next we show for any βC, gj(βC, 0) and
E [Cov∗(Zj,P[δ = 1 | Z] | ZC)] have the opposite signs unless they are equal to zero.
This fact implies that βj 6= 0. Specifically, note that P(δ = 1 | Z) is the probability
of occurring the event and ST (t | Z)SC(t) = P(X > t | Z) represents the probability
at risk at time t. Based on Model (1), for any t,
∂P(X > t | Z)
∂Zj
× ∂P(δ = 1 | Z)
∂Zj
≤ 0.
By Proposition 3, Cov∗(Zj,P[δ = 1 | Z] | ZC) and Cov∗[Zj, ST (t | Z)SC(t) | ZC] have
the opposite signs unless they are zero. This further implies that for any βC,
gj(βC, 0) =
∫ τ
0
E[exp(ZTCβC)Cov
∗[Zj, ST (t | Z)SC(t) | ZC]]
E[exp(ZTCβC)ST (t | Z)SC(t)]
×E [exp(ZTα)ST (t | Z)λ0(t)SC(t)] dt.
and E [Cov∗(Zj,P[δ = 1 | Z] | ZC)] have opposite signs unless they are equal to zero.
Therefore, βj 6= 0.
7.2 Proof of Theorem 2
Proof. For any j ∈M−C, we have βj 6= 0 by Theorem 1, by mean value theorem, for
some β˜j ∈ (0, βj),
|vj(βC,j, 0)| = |vj(βC,j, βj)− vj(βC,j, 0)| =
∣∣∣∣∂vj∂β (βC,j, β˜j)
∣∣∣∣ |βj|,
Next we show that
∣∣∣∂vj∂β (βC,j, β˜j)∣∣∣ is bounded. For given any βC, consider gj(βC, β) as
a function of β, Then
∂gj
∂β
(βC, β) = E
[∫ τ
0
Hj(t,βC, β)SC(t)dFT (t | Z)
]
.
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where
Hj(t,βC, β) =
E[exp(ZTCβC)Cov
∗[Z2j exp(Zjβ), ST (t | Z) | ZC]]
E[exp(ZTCβC + Zjβ)ST (t | Z)]
−E[exp(Z
T
CβC)Cov
∗[Zj exp(Zjβ), ST (t | Z) | ZC]]E[Zj exp(ZTCβC + Zjβ)ST (t | Z)]
[E[exp(ZTCβC + Zjβ)ST (t | Z)]]2
By Condition 2.1, P(|Z| < K0) = 1, then supβC ,β |Hj(t,βC, β)| ≤ 2K20 . Thus,∣∣∣∣∂vj∂β (βC,j, β˜j)
∣∣∣∣ ≤ sup
βC ,β
∣∣∣∣∂gj∂β (βC, β)
∣∣∣∣ ≤ 2K20 |E[E[SC(T ) | Z]] ≤ 2K20 .
By the proof in Theorem 1, g(βC,j, 0) and E [Cov
∗(Zj,E{FT (C | Z) | Z} | ZC)] have
the opposite signs, and by Condition 2,
|vj(βC,j, 0)| = |E [Cov∗(Zj,P[δ = 1 | Z] | ZC)] |+ |gj(βC,j, 0)| > c1n−κ.
Taking c2 = 0.5K
−2
0 c1, βj > 0.5K
−2
0 |vj(βC,j, 0)| > c2n−κ. This completes the proof.
7.3 Proof of Theorem 3
Proof. For any j /∈ C and k ∈ C ∪ {j}, by Lin and Wei (1989), we have
Vj(βC, β) = En{Wi,j(βC, β)}+ op(1),
where En[·] denotes the empirical measure, which is defined as En[ξi] = n−1
∑n
i=1 ξi
for any random variables ξ1, . . . , ξn, and Wi,j(βC, β) are independent over i, and
write Wi,j(βC, β) = [Wi,j,k(βC, β), k ∈ C ∪ {j}]T with
Wi,j,k(βC, β) =
∫ τ
0
{
Zi,k −
r
(1)
j,k (βC, β, t)
r
(0)
j,k (βC, β, t)
}
dNi(t)
−
∫ τ
0
Yi(t) exp(Zi,Cβ
T
C + Zi,jβ)
r
(0)
j,k (βC, β, t)
{
Zi,k −
r
(1)
j,k (βC, β, t)
r
(0)
j,k (βC, β, t)
}
dE[Ni(t)].
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Note that given any i, j, k, with probability one |Wi,j,k(βC, β)| are uniformly bounded.
Specifically, by Conditions 1.2, 2.1 and 3, with probability one, for all t ∈ [0, τ ],
(βTC , β)
T ∈ Bj, ∣∣∣∣∣Zi,k − r
(1)
j,k (βC, β, t)
r
(0)
j,k (βC, β, t)
∣∣∣∣∣ ≤ |Zi,k|+K0,∣∣∣∣∣Yi(t) exp(Zi,CβTC + Zi,jβ)r(0)j,k (βC, β, t)
∣∣∣∣∣ ≤ exp{K0(K1 + δ)− log(L)},
and ∣∣∣∣∫ τ
0
dE[Ni(t)]
∣∣∣∣ ≤ Λ0(τ) exp(K0K1).
Thus, with probability one,
|Wi,j,k(βC, β)| ≤ K2,
whereK2 = 2K0(1+Λ0(τ) exp(2K0K1+K0δ−logL)). By the fact that E[Wi,j,k(βC, β)] =
0,
Var[Wi,j,k(βC, β)] = E[|Wi,j,k(βC, β)|2] < K22
By Lemma 2.2.9 (Bernsterin’s inequality) of Van Der Vaart and Wellner (1996),
for any t > 0, for all j, k, βC and β, we have
P
(
|En(Wi,j,k(βC, β))| >
t
n
)
≤ 2 exp
(
−1
2
t2
nK22 +K2t/3
)
.
Note that the above inequality holds for every j /∈ C and k ∈ C ∪ {j}. By Bonferroni
inequality,
P
(
‖En(Wi,j(βC, β))‖2 >
t
(q + 1)n
)
≤ 2(q + 1) exp
(
−1
2
t2
nK22 +K2t/3
)
.
Since,
‖Vj(βC, β)− En(Wi,j(βC, β))‖2 = op(1).
Then for any 1 > 0 and 2 > 0, there exits N1, such that for any n > N1
P(‖Vj(βC, β)− En(Wi,j(βC, β))‖2 > M1/2) < 2.
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where M is the same value in Condition 4. By Triangle inequality and Bonferroni
inequality, we have
P
(
‖Vj(βC, β)‖2 >
t
(q + 1)n
)
≤ P
(
‖En(Wi,j(βC, β))‖2 >
t
(q + 1)n
−M1/2
)
+ P(‖Vj(βC, β)− En(Wi,j(βC, β))‖2 > M2/2)
When n→∞, take t = c2M(q + 1)n1−κ/2 > 0 on both side of the inequality, where
c2 is the same value in Theorem 2, we have
P
(
‖Vj(βC, β)‖2 >
Mc2
2
(n−κ − 1)
)
≤ 2(q + 1) exp
(
− M
2c22
8(q + 1)2
n1−2κ
K22 +K2n
−κ/3
)
+ 2.
Take N = max{d(K2/3)1/κe, N1}, then for any n > N , n−κ < 3/K2, and
P
(
‖Vj(βC, β)‖2 >
Mc2
2
(n−κ − 1)
)
≤ 2(q + 1) exp
(
− M
2c22
8(q + 1)2
n1−2κ
K22 + 1
)
+ 2.
Note that the above inequality holds for all (βTC , β)
T ∈ Bj, particularly for (βTC,j, βj)T,
j /∈ C. Also, we have Vj(β̂C,j, β̂j) = 0q+1. By Condition 4, we have
P
(
|β̂j − βj| > c2
2
(n−κ − 1)
)
≤ P
(
‖(β̂TC,j, β̂j)T − (βTC,j, βj)T‖2 >
c2
2
(n−κ − 1)
)
≤ 2(q + 1) exp
(
− M
2c22
8(q + 1)2
n1−2κ
K22 + 1
)
+ 2.
Taking c3 =
M2c22
8(q+1)2(K22+1)
and by Bonferroni completes the proof for part 1.
For part 2, by Theorem 2,
min
j∈M−C
|βj| > c2n−κ.
Note that, for any j ∈M−C, event{
|β̂j − βj| ≤ c2n−κ/2− 1
}
⊆
{
|β̂j| ≥ |βj| − c2n−κ/2 + 1
}
⊆
{
|β̂j| ≥ c2n−κ/2 + 1
}
.
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Take γn = c4n
−κ with c4 = c2/4,{
max
j∈M−C
|β̂j − βj| ≤ c2n−κ/2− 1
}
⊆
{
min
j∈M−C
|β̂j| ≥ c2n−κ/2 + 1
}
⊆
{
min
j∈M−C
|β̂j| ≥ γn + 1
}
.
Thus,
P
[
M−C ⊆ M̂−C
]
= P
[
min
j∈M−C
|β̂j| > γn
]
≥ P
[
min
j∈M−C
|β̂j| > γn + 1
]
≥ 1− P
[
max
j∈M−C
|β̂j − βj| ≤ c2n−κ/2− 1
]
≥ 1− 2w(q + 1) exp(−c3n1−2κ)− 2.
Let n→∞, we have for any 2 > 0,
lim
n→∞
P
[
M−C ⊆ M̂−C
]
≥ 1− 2.
Note that the left side of the above equation does not depends on n any more. Taking
2 → 0 completes proof.
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